Home Technology Pipeline Our Team Contact Us
Developing Next Generation for the treatment of

Scientific Advisory Board

Emil CoccaroEmil F. Coccaro, M.D., is currently the Ellen C. Manning Professor and Chairman of the Department of Psychiatry & Behavioral Neuroscience at the Pritzker School of Medicine, University of Chicago. Dr. Coccaro has been the recipient of various awards, including the A.E. Bennett Award for Outstanding Research (1989) and the National Alliance for the Mentally Ill’s Exemplary Psychiatrist Award (1992). He also serves on the editorial boards of several journals, among them International Clinical Psychopharmacology, Journal of Personality Disorders, and Aggression and Violent Behavior. In addition, he is the Impulse Control and Personality Disorders Section Editor for Current Psychiatry Reports. Dr. Coccaro has been the recipient of a number of research grants from the National Institute of Mental Health, the American Foundation for Suicide Prevention, the Borderline Personality Disorder Research Foundation, and the Harry Frank Guggenheim Foundation. Dr. Coccaro is the author or co-author of over 130 peer-reviewed journal articles, as well as 175 abstracts and 40 book chapters. He has edited or co-edited three books, most recently, Aggression: Psychiatric Assessment and Treatment, published by Marcel Dekker. He lectures widely on topics such as mood and personality disorders and the neuroscience, neuropsychopharmacology, genetics, and treatment of impulsive aggressive behavior.

Dr. Coccaro received his undergraduate B.S. degree in Biology from Fordham University, where he graduated Magna Cum Laude in 1975. He continued his studies at the New York University School of Medicine, completing his M.D. degree in 1979. After a medical internship at the University of Cincinnati Medical Center and a psychiatric residency at the Mount Sinai Medical Center in New York City, Dr. Coccaro joined the faculty of the Department of Psychiatry at the Mount Sinai School of Medicine in 1983. In 1989, Dr. Coccaro moved to Philadelphia to found and direct the Clinical Neuroscience Research Unit at the MCP Hahnemann School of Medicine. Dr. Coccaro moved to the Pritzker School of Medicine as the Director of the Clinical Neuroscience & Psychopharmacology Research Unit in September 1999. He became Chairman of the Department in November 2004. Dr. Coccaro is a Distinguished Fellow of the American Psychiatric Association (APA) and a Fellow of the American College of Neuropsychopharmacology (ACNP).

Stephen J. Benkovic, Ph.D., is Evan Pugh Professor holder of the Eberly Chair in Chemistry at Penn State University. His work has been recognized by awards and fellowships including: Alfred P. Sloan Fellowship, NIH Career Development Award, Guggenheim Fellowship, the Pfizer Award in Enzyme Chemistry, the Gowland Hopkins Award, the Repligen Award for Chemistry of Biological Processes, the Alfred Bader Award, the Chemical Pioneer Award from the American Institute of Chemists, the Christian B. Afinsen Award, and the Benjamin Franklin Medal in Life Sciences. He has been elected to memberships in the American Academy of Arts and Sciences, the National Academy of Sciences, the Institute of Medicine, National Academy of Sciences, and the American Philosophical Society. Dr. Benkovic has advised life science venture funds and served as Chair of the Scientific Advisory Board at GSK. Dr. Benkovic received his B.S. degree in Chemistry and A.B. degree in English Literature from Lehigh University, the Ph.D. in Organic Chemistry from Cornell University, and was a postdoctoral research associate at the University of California, Santa Barbara.

Ned Heindel, Ph.D., is the Howard S. Bunn Chair Professor of Chemistry at Lehigh University where he has conducted research and taught since 1966. At Lehigh, Dr. Heindel’s research has involved the development of diagnostic and therapeutic products under the support of nine pharmaceutical companies, three federal agencies, and four foundations. He has consulted in big and small pharma, and has mentored 40 doctoral students, 131 M.S. students, and 23 postdoctoral fellows most of whom undertook careers inside the pharmaceutical industry. Dr. Heindel has served on two corporate boards, five science advisory boards, three editorial boards, and four professional boards.

In 1994, Dr. Heindel served as national President of the American Chemical Society. His awards have included two honorary doctorates, the Robinson Award , the Briody Award, the L. W. Brady Cancer Achievement Award, the Henry Hill Award in Medicinal Chemistry, the Mosher Award for Contributions to Chemistry, and the Ben Franklin Partnership Award for Corporate Collaborations. He holds a PhD from the University of Delaware and was an NSF Postdoctoral Fellow at Princeton University.

Marvin Miller, Ph.D., a member of Azevan's Scientific Advisory Board, is the George and Winifred Clark Chair Professor of Chemistry and Biochemistry at the University of Notre Dame. His research group is internationally recognized for its expertise in synthetic organic, bioorganic and medicinal chemistry. Dr. Miller has published extensively, his group has several patents, and he has presented over 150 invited lectures worldwide. His research has been fully funded for over 20 years by the NIH, private foundations and industry. Prof. Miller was a Fellow of the Alfred P. Sloan Foundation (1981-1985) and received an NIH Career Development Award (1983-1988). He has served on the editorial advisory board of several major journals, on NIH study sections, and review panels for several other funding agencies. Prof. Miller has been a consultant for several pharmaceutical and biotech companies. He is a member of the scientific advisory boards for NewBiotics and North Dakota Sate Univesity Center for Protease Research (NIH COBRA Center). He received his bachelor's degree in chemistry from North Dakota State University, a Ph.D. from Cornell University and was an NIH postdoctoral fellow at the University of California at Berkeley.

Meir Steiner, M.D., Ph.D. FRCPC joined the Dept. of Psychiatry at McMaster University in 1981. He has served as head of the Clinical Studies Program, Chief and Clinical Director of the department, and Director of Research. Since 1988, he has been Director of the Women's Health Concerns Clinic. In addition to his current positions as Professor of Psychiatry and Behavioural Neurosciences, Dr. Steiner holds additional appointments at the University of Toronto.

Professor Steiner's primary areas of research and publications have been the pathophysiology and psychopathology of mood disorders related to women's reproductive cyclicity. Since 1970, he has more than 600 publications, abstracts, preliminary communications and panel discussions in the field. He serves on the editorial or advisory boards of several professional journals and has co-authored and edited several books related to mood disorders in women.

Professor Steiner is a member of many professional societies, and in 2000 the CCNP awarded him the Heinz Lehman Award for outstanding contributions in neuropsychopharmacology.. Professor Steiner is the Past President and the current Development Officer of the North American Society for Psychosocial Obstetrics and Gynecology. He serves on the Executive Board of The Marce Society and on the Isis Network on "Sex, Gender, Drugs and the Brain" for the Society of Women's Health Research. Professor Steiner graduated magna cum laude receiving his MD from the Tel Aviv University in 1968 and his PhD in Neurosciences in 1979 from the University of Michigan, Ann Arbor.

Bruce Leuchter, M.D., is the Director of Clinical Neuropsychiatry and NeurostimulationTherapies at Weill Cornell Medical College. Dr. Leuchtercompleted an internship in Internal Medicine and dual residencies in Neurology and Psychiatry at New York PresbyterianHospital, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College. He went on to complete a post‐doctoral research fellowship in Brain Stimulation and Therapeutic Neuromodulation at Columbia University. Dr. Leuchter was appointed to the faculty of Weill Cornell Medical College in July 2006, where he led academic, research, and clinical initiatives for the Division of Neuropsychiatry.

Dr. Leuchter joined Goldman Sachs & Co. in 2008 to spearhead a new venture focused on emerging biotechnologies in Neuroscience. In this role, he sought to identify potentially disruptive therapeutics, devices, and diagnostics at biotechnology companies through detailed analysis of competitive landscapes and market dynamics in areas of high unmet medical need. Dr. Leuchter returned to Weill Cornell Medical College in July 2009 to accept the position of Director of Clinical Neuropsychiatry and NeurostimulationTherapies. His current research and clinical activities focus on neuropsychopharmacologyand the emerging field of brain stimulation. Dr. Leuchter directs the research and clinical programs in Transcranial Magnetic Stimulation and Deep Brain Stimulation for the Department of Psychiatry at WeillCornell Medical College.